Proteomic analysis of plasma from patients during an acute coronary syndrome
- 13 October 2004
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 44 (8), 1578-1583
- https://doi.org/10.1016/j.jacc.2004.06.073
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary SyndromesCirculation, 2003
- Soluble CD40LCirculation, 2003
- Acute Release of Plasminogen Activator Inhibitor-1 in ST-Segment Elevation Myocardial Infarction Predicts MortalityCirculation, 2003
- Troponin: an important prognostic marker and risk-stratification tool in non–ST-segment elevation acute coronary syndromesJournal of the American College of Cardiology, 2003
- Myocardial damage, inflammation and thrombin inhibition in unstable coronary artery disease.Published by Oxford University Press (OUP) ,2003
- Proteomic analysis of human prostate cancer†Molecular Carcinogenesis, 2002
- Proteomics: a new approach to the study of diseaseThe Journal of Pathology, 2000
- Proteomics and molecular medicineNature Biotechnology, 1999
- Anti-Neutrophil-Elastase Defenses of the Lower Respiratory Tract in α1-Antitrypsin Deficiency Directly Augmented with an Aerosol of α1-AntitrypsinAnnals of Internal Medicine, 1989
- HUMAN PLASMA PROTEINASE INHIBITORSAnnual Review of Biochemistry, 1983